Kennedy’s commitment to walk away from the potential windfall is a major reversal for the nominee, who in his ethics plan ...

Merck & Co (NYSE:MRK)., the second-largest U.S. drugmaker by revenue, is facing a jury trial over accusations that it ...

RFK Jr. said he would give up the fees after senators questioned him about the lawsuits in a pair of hearings.

Sens. Elizabeth Warren and Ron Wyden criticized RFK Jr. over how he's handling potential profits from litigation over an HPV ...

Senators had objected to the financial conflict posed by Robert F. Kennedy Jr.’s decision to retain a financial stake in ...

Robert F. Kennedy Jr. also disclosed that he had reached at least one settlement agreement with a company or individual that ...

Robert F. Kennedy Jr., Trump's pick to head the Department of Health and Human Services, faces scrutiny for fees he may earn from lawsuits against Merck.

President Donald Trump’s Health and Human Services nominee said he will divest his interest in lawsuits against an HPV ...

Lastly, it saw an improvement in gross margins, thanks to lower royalty rates for Keytruda and Gardasil. 2024 was also the year where Merck looked at inorganic growth to expand its pharmaceuticals ...

Wisner Baum is representing a plaintiff in a trial against Merck and other lawsuits are ... in Wisner Baum's suits against Merck over its HPV vaccine, which is to prevent cervical cancer.